Literature DB >> 26563166

The First Case of Invasive Mixed-Mold Infections Due to Emericella nidulans var. echinulata and Rasamsonia piperina in a Patient with Chronic Granulomatous Disease.

Naruhiko Ishiwada1, Kenichi Takeshita2, Takashi Yaguchi3, Koo Nagasawa2, Noriko Takeuchi4, Haruka Hishiki2, Akira Watanabe4, Katsuhiko Kamei4, Naoki Shimojo2.   

Abstract

A 16-year-old boy with chronic granulomatous disease presented with pneumonia and rib osteomyelitis. Emericella nidulans var. echinulata was isolated from his sputum. After starting voriconazole, Rasamsonia piperina was isolated from the rib swelling. A combination therapy of voriconazole and micafungin effectively eradicated this invasive mixed-mold infection. In immunocompromised patients, a precise pathogenic diagnosis is clinically useful for administration of an appropriate treatment regimen.

Entities:  

Keywords:  Chronic granulomatous disease; Emericella nidulans var. echinulata; Micafungin; Rasamsonia piperina; Voriconazole

Mesh：

Substances：

Year:  2015        PMID： 26563166     DOI： 10.1007/s11046-015-9963-5

Source DB:  PubMed          Journal:  Mycopathologia        ISSN： 0301-486X            Impact factor:   2.574


  16 in total

1.  Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.

Authors:  Jin Yu; Xiangdong Mu; Ruoyu Li
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

Review 2.  Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature.

Authors:  John Dotis; Emmanuel Roilides
Journal:  Mycoses       Date:  2011-05-25       Impact factor: 4.377

3.  Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease.

Authors:  Suk See De Ravin; Malliswari Challipalli; Victoria Anderson; Yvonne R Shea; Beatriz Marciano; Dianne Hilligoss; Martha Marquesen; Rosamma Decastro; Yen-Chun Liu; Deanna A Sutton; Brian L Wickes; Patricia L Kammeyer; Lynne Sigler; Kathleen Sullivan; Elizabeth M Kang; Harry L Malech; Steven M Holland; Adrian M Zelazny
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

Review 4.  Genetic, biochemical, and clinical features of chronic granulomatous disease.

Authors:  B H Segal; T L Leto; J I Gallin; H L Malech; S M Holland
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

5.  A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.

Authors:  Toshiaki Matsuda; Yoshimizu Koreeda; Hiroko Mataki; Tetsuhiko Taira; Satoshi Noma; Ikkou Higashimoto
Journal:  Intern Med       Date:  2010-06-15       Impact factor: 1.271

6.  Taxonomy and antifungal susceptibility of clinically important Rasamsonia species.

Authors:  J Houbraken; S Giraud; M Meijer; S Bertout; J C Frisvad; J F Meis; J P Bouchara; R A Samson
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

7.  Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan.

Authors:  Shinichi Kobayashi; Shizuko Murayama; Sayaka Takanashi; Kumiko Takahashi; Sachiko Miyatsuka; Tomoko Fujita; Sadato Ichinohe; Yuichi Koike; Toshitaka Kohagizawa; Hirosumi Mori; Yasushi Deguchi; Kaoru Higuchi; Hiroaki Wakasugi; Tatsuya Sato; Yasuyuki Wada; Masato Nagata; Nobuhiko Okabe; Osamu Tatsuzawa
Journal:  Eur J Pediatr       Date:  2008-03-12       Impact factor: 3.183

Review 8.  Aspergillus nidulans infection in chronic granulomatous disease.

Authors:  B H Segal; E S DeCarlo; K J Kwon-Chung; H L Malech; J I Gallin; S M Holland
Journal:  Medicine (Baltimore)       Date:  1998-09       Impact factor: 1.889

Review 9.  A case of chronic necrotizing pulmonary aspergillosis due to Aspergillus nidulans.

Authors:  M Mizuki; K Chikuba; K Tanaka
Journal:  Mycopathologia       Date:  1994-11       Impact factor: 2.574

Review 10.  Emericella quadrilineata as cause of invasive aspergillosis.

Authors:  Paul E Verweij; János Varga; Jos Houbraken; Antonius J M M Rijs; Frans M Verduynlunel; Nicole M A Blijlevens; Yvonne R Shea; Steven M Holland; Adilia Warris; Willem J G Melchers; Robert A Samson
Journal:  Emerg Infect Dis       Date:  2008-04       Impact factor: 6.883
View more
  5 in total

Review 1.  Enzymatic Mechanisms Involved in Evasion of Fungi to the Oxidative Stress: Focus on Scedosporium apiospermum.

Authors:  C Staerck; P Vandeputte; A Gastebois; A Calenda; S Giraud; N Papon; J P Bouchara; M J J Fleury
Journal:  Mycopathologia       Date:  2017-06-21       Impact factor: 2.574

2.  The Curious Case of "Case Report" of Infections Caused by Human and Animal Fungal Pathogens: An Educational Tool, an Online Archive, or a Format in Need of Retooling.

Authors:  Jean-Philippe Bouchara; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2018-12       Impact factor: 2.574

3.  Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients.

Authors:  Abdelmounaim Mouhajir; Olivier Matray; Sandrine Giraud; Laurent Mély; Christophe Marguet; Isabelle Sermet-Gaudelus; Solène Le Gal; Franck Labbé; Christine Person; Françoise Troussier; Jean-Jacques Ballet; Gilles Gargala; Rachid Zouhair; Marie-Elisabeth Bougnoux; Jean-Philippe Bouchara; Loïc Favennec
Journal:  J Clin Microbiol       Date:  2016-09-07       Impact factor: 5.948

4.  Systemic Rasamsonia piperina infection in a German shepherd cross dog.

Authors:  Joanna Lodzinska; Paola Cazzini; Claire S Taylor; Jenifer Harris; Scott Kilpatrick; Tiziana Liuti; Gavin K Paterson
Journal:  JMM Case Rep       Date:  2017-10-18

Review 5.  Taxonomy and evolution of Aspergillus, Penicillium and Talaromyces in the omics era - Past, present and future.

Authors:  Chi-Ching Tsang; James Y M Tang; Susanna K P Lau; Patrick C Y Woo
Journal:  Comput Struct Biotechnol J       Date:  2018-05-31       Impact factor: 7.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.